Advanced Level: Trending of Process Data for OPV/CPV - Online Training Recording

Course No. 22655

header-image

Speakers

Dr. Raphael Bar

Dr. Raphael Bar

BR Consulting



Target Group

This is an advanced level course, therefore a knowledge on control charts is an advantage. Employees from companies, who are involved in pharmaceutical process validation activities (developers, QM, manufacturing, heads of validation departments, etc.) especially regarding stage 3 Ongoing/Continued Process Verification, are addressed. Of course consultants in this field, who want to get information from the view of the medicinal product manufacturers, are addressed too.

Objectives

This is an advanced level course divided into three half-day parts on 15-17 October 2025.

You will learn:

  • What is Ongoing/Continued Process Verification
  • Overview of Control Charts of grouped and individual data
  • Overview of Three-Way charts
  • Overview of Attributes charts
  • Stability and capability of a process
  • Tools for detecting a trend and shift in process average and/or process variability
  • Reasons for too many statistical false signals in real-life process data
  • Ways to minimize false signals in real-life pharmaceutical and biopharmaceutical processes
  • Components of a CPV/OPV plan
  • Integration a practical SPC approach into the CPV/OPV plan
  • Examples of control charts of real-life data of pharmaceutical processes, generated with StatGraphics, will be shown throughout the course
Background
FDA´s Process Validation Guidance and Annex 15 to the EU GMP Guide require manufacturers to monitor product quality to ensure that a State of Control is maintained throughout the validation lifecycle of new products and legacy products during the third process validation stage called Continued Process Verification (CPV) or Ongoing Process Verification (OPV). Indeed, regulatory agencies expect manufacturers to implement also a CPV plan as reflected in FDA warning letters.

The implementation of Stage 3 is translated into establishing an ongoing CPV/OPV program which allows Identification of CPV/OPV signals and defining types of responses to these signals. However, real-life data of pharmaceutical and biopharmaceutical processes rarely meet the fundamental assumtioms of the conventional SPC (Statistical Process Control). This in turn leads often to false signal alarms, which entail futile investigations of innocuous events. Thus, a practical approach is called for and it consists of collecting, charting and evaluating product and process data under relaxed and adjusted SPC rules, allowing a streamlined implementation of the CPV/OPV program.


Programme

Introduction

  • What is Ongoing/Continued Process Verification?
  • Regulations
  • What data to trend
  • Process inputs and outputs: CPP and CQA
  • NOR, PAR and Design Space
  • Run Chart versus Control Chart
  • Common cause variation versus special variation
  • "State of Control"

Overview of Control Charts of Variables I

  • Overview of Control Charts of grouped data
  • Overview of Control Charts of individual data
  • Overview of Three-Way Charts

Overview of Control Charts of Variables II

  • Capability indices (Cp, Cpk, Pp and Pk)
  • Stability and capability of a process
  • Examples: control charts of Assay, impurity, of UOC, dissolution

Overview of Control Charts of Attributes

  • Their use in the pharmaceutical industry
  • Np and p control charts
  • c and u control Charts
  • Examples: control Np charts of inspected packages (defective), c charts of non-conformities (defects) in labels of a drug product; c chart of environmental microbial counts

Detecting Drifts and Trends

  • Pattern and Trends in Data
  • Moving Averages
  • Nelson Rules
  • Detecting small shifts
  • Simple Cusum Charts

Evaluation of a Control Chart

  • Nelson rules for detecting trends and shifts
  • "State of Control" versus "State of Statistical Control"
  • Phase I and Phase II in control charting
  • "Statistical Limits" versus "Regulatory Limits"
  • Are all statistical assumptions valid in real-world pharmaceutical process data?

Adjusting SPC Rules to Pharmaceutical Process Data

  • Which statistical rules can be relaxed
  • Setting practical limits
  • Examples of process behaviour charts
  • Components of a CPV/OPV Plan
  • Identification of CPV Signals
  • Types of responses to Signals

Structure of OPV/CPV Plan

  • Basic components of an OPV/CPV Plan
  • Set of SOPs
  • Identification of OPV/CPV signals
  • What level of monitoring?
  • Types of responses to OPV/CPV signals
  • Roadmap of OPV/CPV Plan

Policy of OPV/CPV Implementation

  • Recommendations for a GMP-compliant implementation
  • Artificial Intelligence in OPV/CPV


Further Information

To participate in an on demand training course or webinar, you do not need any software. The recordings are made available via a streaming server. In general, the recording is provided in MP4 format, which any PC (Microsoft Windows, Apple IOS) or tablet can easily display.

Timing and Duration:
When you register for the on demand Training course or webinar you can decide at what date you want to follow the training course online. For a 1-day training course you will have 2 days in which the stream is available (for 2-day training course 3 days and for a 3-day training course 4 days). Within in this timeframe you can start & stop the stream according to your needs.

In time before the scheduled date (your desired date) you will receive an e-mail from us with a link for direct participation as well as your log-in data.

Please be aware: The recording does not include the Q & A sessions.

Training Course Documentation and Certificate:
The presentation will be made available as PDF-files via download during the online training course. After the successful completion of the online training, you are able to download the certificate of attendance.

Contacts
Questions regarding content:
Mr Sven Pommeranz, +49 (0)6221 84 44 47, pommeranz@concept-heidelberg.de
Questions regarding organisation:
Mr Ronny Strohwald, +49 (0)6221 84 44 51, strohwald@concept-heidelberg.de

Recording from 15-17 October 2025
Duration of Recording: 8 hours 40 min

Costs

ECA-Member*: € 1590,-
Regular Fee*: € 1790,-
EU/GMP Inspectorates*: € 895,-
APIC Member Discount*: € 1690,-

(All prices excl. VAT). Important notes on sales tax.

* also payable by credit card
American Express Visa Mastercard

icon
Recording/ Additional dates on-site
not available
Recording/ Additional dates on-site
not available
stop

This course is part of the GMP Certification Programme "ECA Certified Validation Manager"

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org

Woman with headset

Go back

Testimonials about our courses and conferences

"Great material and speakers" and "Great speakers a lot of experience and sharing"

Felipe Gonzalez, Mucos Emulsionsgesellschaft mbH
Live Online Training - Granulation & Tableting, September 2024

“I found the course eye opening and very well organized.”

Jozsef Maklary, Veolia Industries Austria GmbH
The GMP-Compliance Manager, October 2025

"I am so grateful for having attended this course. Great job from all, and very profitable. Thanks!”

Alba Aranda Cuesta, Kern Pharma
KPIs and Quality Metrics, Berlin, Germany, April 2025

"The lectures were very informative, interesting and entertaining."

Albert Godoy Hernández, Company synaffix
Live Online Training - GMP Auditor Practice, October 2024

"Really useful training which I will use in my daily work."

Regina Mommaerts, Galapagos NV
Live Online Training - GMP Auditor Practice, October 2024

"Wonderful format of the sessions: Good range of participations and experience in the team. Would love to attend another one soon."

Roopasi Mathi, Wacker Biotech B.V.
Live Online Training - GMP Auditor Practice, October 2024

"Very good balance between general and detailed information"

Dr Ralf Albrecht, Tillotts Pharma AG
Live Online Training - Granulation & Tableting
September 2024

"Nice presentations: easy understanding, quite visual"

Susana Manrique, Boehringer Ingelheim España, S.A,
Live Online Training - Granulation & Tableting, September 2024

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023

 

“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024

 

“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024

 

 

“Both, organizers and lecturers were very friendly, open for discussions and extremely constructive. The course was a valuable experience for me.”

Maria Dimitrova, NKN Law Firm
Pharmaceutical Contracts: GMP and Legal Compliance, March 2025